Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
26M
-
Number of holders
-
61
-
Total 13F shares, excl. options
-
6.87M
-
Shares change
-
+3.01M
-
Total reported value, excl. options
-
$110M
-
Value change
-
+$42.9M
-
Number of buys
-
30
-
Number of sells
-
-20
-
Price
-
$16.12
Significant Holders of Cartesian Therapeutics, Inc. - COMMON STOCK (RNAC) as of Q3 2024
73 filings reported holding RNAC - Cartesian Therapeutics, Inc. - COMMON STOCK as of Q3 2024.
Cartesian Therapeutics, Inc. - COMMON STOCK (RNAC) has 61 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.87M shares
of 26M outstanding shares and own 26.44% of the company stock.
Largest 10 shareholders include FMR LLC (2.85M shares), MPM BIOIMPACT LLC (629K shares), Siren, L.L.C. (572K shares), BlackRock, Inc. (423K shares), CITADEL ADVISORS LLC (376K shares), JPMORGAN CHASE & CO (309K shares), VANGUARD GROUP INC (243K shares), GREAT POINT PARTNERS LLC (200K shares), Erste Asset Management GmbH (174K shares), and STATE STREET CORP (157K shares).
This table shows the top 61 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.